Associate Professor of Ophthalmology

Glaucoma Service

Medical School

Louisiana State University Medical Center

Doctorate

Physical Chemistry, University of New Orleans

Residency

Louisiana State University Eye Center

Fellowship

Wilmer Eye Institute, Johns Hopkins University School of Medicine

Phone

919.684.8850

Fax

919.681.8267

Research Interests

Stuart McKinnon, MD, PhD, specializes in the diagnosis and treatment of glaucoma and cataract. His areas of expertise include open and closed angle glaucomas, neovascular and other secondary glaucomas, and juvenile glaucoma. He is experienced in all forms of anterior segment procedures including laser therapy and filtering surgeries for glaucoma, as well as cataract surgery. He is integrally involved in the teaching of medical students, residents, and fellows. McKinnon's research activities include NIH-sponsored exploration of the basic mechanisms of retinal cell death in glaucoma. Other research areas include neuroprotective glaucoma therapies, non-invasive imaging of glaucoma damage, and relationships between glaucoma and other chronic neurodegenerations such as Alzheimer's disease.

Representative Publications

1. Jacob JT, Burgoyne CF, McKinnon SJ, Tanji TM, LaFleur PK, Duzman E. Biocompatibility response to modified Baerveldt glaucoma drains. J Biomed Mater Res 1998:43:99-107.
2. Pease ME, McKinnon SJ, Quigley HA, Kerrigan LA, Zack DJ. Obstructed Axonal Transport of BDNF and Its Receptor TrkB in Experimental Glaucoma. Invest Ophthalmol Vis Sci 2000:41:764-774.
3. Quigley HA, McKinnon SJ, Zack DJ, Pease ME, Kerrigan–Baumrind LA, Kerrigan DF, Mitchell RS. Retrograde Axonal Transport of BDNF in Retinal Ganglion Cells Is Blocked by Acute IOP Elevation in Rats. Invest Ophthalmol Vis Sci 2000:41:3460-3466.
4. Sponsel WE, Paris G, Trigo Y, Pena M, Weber A, Sanford K, McKinnon SJ. Latanoprost and Brimonidine: Therapeutic and Physiologic Assessment Before and After Oral Nonsteroidal Anti-inflammatory Therapy. Am J Ophthalmol 2002:133:11-18.
5. McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, Merges CA, Pease ME, KerriganDF, Ransom NL, Tahzib NG, Reitsamer HA, Levkovitch-Verbin H, Quigley HA, Zack DJ. Caspase Activation and Amyloid Precursor Protein Cleavage in Rat Ocular Hypertension. Invest Ophthalmol Vis Sci 2002:43:1077-1087.
6. McKinnon SJ, LehmanDM , Tahzib NG, Ransom NL, Reitsamer HA, Liston P, LaCasse E, Li Q, Korneluk RG, Hauswirth WW. Baculoviral IAP Repeat-Containing-4 Protects Optic Nerve Axons in a Rat Glaucoma Model. Molecular Therapy 2002:5:780-787.
7. McKinnon SJ. Glaucoma: Ocular Alzheimer’s Disease? Front Biosci 2003:8:1140-1156.
8. Mayo GL, Melendez RF, Kumar N, McKinnon SJ, Glickman RD. Antibody-targeted photodynamic therapy. Am J Ophthalmol 2003:136:1151-1152.
9. Tahzib NG, Ransom NL, Reitsamer HA, McKinnon SJ. Alpha-fodrin is Cleaved by Caspase-3 in a Chronic Ocular Hypertensive (COH) Rat Model of Glaucoma. Brain Res Bull 2004:62:491-495.
10. Reitsamer HA, Kiel JW, Harrison JM, Ransom NL, McKinnon SJ. Tonopen Measurements of Intraocular Pressure in Mice. Exp Eye Res 2004:78:799-804.